Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
Injection drug use (IDU) and heterosexual virus transmission both contribute to the growing mixed HIV epidemics in Eastern Europe and Central Asia. In Ukraine-chosen in this study as a representative country-IDU-related risk behaviors cause half of new infections, but few injection drug users (IDUs)...
Main Authors: | Sabina S Alistar, Douglas K Owens, Margaret L Brandeau |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-03-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3046988?pdf=render |
Similar Items
-
Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics.
by: Sabina S Alistar, et al.
Published: (2014-01-01) -
Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom.
by: Elisa F Long, et al.
Published: (2014-01-01) -
Piloting work of outreach nurses in Harm Reduction projects in Ukraine
by: Dvinskykh Natalya, et al.
Published: (2012-05-01) -
Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
by: Cora L Bernard, et al.
Published: (2017-05-01) -
Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.
by: Lauren E Cipriano, et al.
Published: (2012-01-01)